Summary of the Study on Palliative Oxygen

Background and Methodology

A study was conducted to compare the effectiveness of palliative oxygen versus room air in relieving breathlessness in patients with refractory dyspnoea. Patients with life-limiting illness and dyspnoea were randomly assigned to receive either oxygen or room air for 7 days. The primary outcome measured was the level of breathlessness twice a day. The study included 239 participants from outpatient clinics in Australia, the USA, and the UK.

(Source: The Lancet 2010, Page 784)

Findings

The study results showed that there was no significant difference in the relief of breathlessness between the oxygen and room air groups. Both groups experienced a reduction in breathlessness levels over the 7-day period. Side effects were similar in both groups, with no significant differences reported. The study concluded that oxygen provided no additional symptomatic benefit compared to room air in relieving refractory dyspnoea in patients with life-limiting illness.

(Source: The Lancet 2010, Page 784)

Discussion

The study highlighted that despite the common use of palliative oxygen for dyspnoea, there is a lack of definitive evidence supporting its efficacy. The findings of this study suggest that less burdensome strategies should be considered for managing breathlessness in these patients. The study emphasized the importance of assessing the individual patient's response to oxygen therapy before prescribing it, as it may not always provide significant relief.

(Source: The Lancet 2010, Page 784)

Amy Abernethy, Sara Booth, Janet Bull, Katherine Clark, Alan Crockett, David Currow et al.- Effect of palliative oxygen versus room air in relief of breathlessness in patients with refractory dyspnoea: a double-blind, randomised controlled trial. - Flipbook by Fleepit